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Abstract 
 
Introduction 
Breast density is one of the strongest risk factors for breast cancer, but determinants of breast 
density in young women remain largely unknown.  
Method 
 Associations of height, adiposity and body fat distribution with percent dense breast volume 
(%DBV) and absolute dense breast volume (ADBV) were evaluated in a cross-sectional study of 
174 healthy women, 25-29 years old. Adiposity and body fat distribution were measured by 
anthropometry and dual-energy x-ray absorptiometry (DXA), while %DBV and ADBV were 
measured by magnetic resonance imaging (MRI). Associations were evaluated using linear 
mixed effects models. All tests of statistical significance are 2-sided.   
Results 
Height was significantly positively associated with %DBV but not ADBV; for each standard 
deviation (SD) increase in height, %DBV increased by 18.7% in adjusted models. In contrast, all 
measures of adiposity and body fat distribution were significantly inversely associated with 
%DBV; a SD increase in body mass index (BMI), percent fat mass, waist circumference and the 
android:gynoid fat mass ratio (A:G ratio) each was associated significantly with a 44.4% - 47.0% 
decrease in %DBV after adjustment for childhood BMI and other covariates. Although 
associations were weaker than for %DBV, all measures of adiposity and body fat distribution 
also were significantly inversely associated with ADBV before adjustment for childhood BMI. 
However, after adjustment for childhood BMI only the DXA measures percent fat mass and A:G 
ratio remained significant; a SD increase in each was associated with a 13.8% - 19.6% 
decrease in ADBV . In mutually adjusted analysis, percent fat mass and the A:G ratio remained 
significantly inversely associated with %DBV, but only the A:G ratio was significantly associated 
with ADBV; a SD increase in A:G ratio was associated with a 18.5% decrease in ADBV.    
Conclusions 
Total adiposity and body fat distribution are independently inversely associated with %DBV, 
whereas in mutually adjusted analysis only body fat distribution (A:G ratio) remained 
significantly inversely associated with ADBV in young women. Research is needed to identify 
biological mechanisms underlying these associations.  
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Introduction 
The breast is comprised of adipose tissue and dense fibroglandular tissue and women with a 
high percent dense breast area (%DBA) or absolute dense breast area (ADBA) measured by 
mammography are at an increased risk of breast cancer. In a meta-analysis risk was increased 
more than 4-fold for women with the highest %DBA.[1] Percent dense breast volume (%DBV) 
and absolute dense breast volume (ADBV) measured by magnetic resonance imaging (MRI) 
and other three-dimensional modalities are similarly positively associated with breast cancer 
risk.[2]  
 
The association of body composition with breast density has been studied extensively. Adiposity 
is strongly inversely associated with %DBA [3-13] and %DBV [12-16] in both premenopausal 
and postmenopausal women. Adiposity also generally is inversely associated with ADBA in 
postmenopausal women,[6-8, 10, 13] but the association is less consistent in premenopausal 
women, with inverse [3, 7, 10] and direct [8, 9, 11] associations reported. The association of 
adiposity with ADBV is more often reported to be direct,[12, 14-16] although inverse [13] and 
null [17] associations also have been reported. Height is positively associated with %DBA in 
some studies,[3, 7, 18] but it is not associated with ADBA in most studies.[3, 6, 10, 11, 18] Only 
one previous study evaluated the association of height with %DBV and ADBV,[16] and in that 
study height was positively associated with both measures of breast density.  
 
Most earlier studies estimated breast density as %DBA and ADBA from mammographic images 
and included older premenopausal and postmenopausal women. Because of the sensitivity of 
the young breast to radiation, few studies have evaluated the association of adiposity and height 
with breast density in girls and young women. Nonetheless, breast density measured by 
mammographic parenchymal pattern was inversely associated with body mass index (BMI) and 
percent truncal fat in a study of 25-35 year olds.[19] Novotny and colleagues [20] used dual-
energy x-ray absorptiometry (DXA) to measure %DBV and ADBV in 10-16 year old girls and 
found that several DXA measures of adiposity were significantly inversely associated with 
%DBV but positively associated with ADBV. Percent fat mass was the strongest predictor of 
%DBV and explained 67 percent of its variability. Using MRI to measure %DBV and ADBV in 
young women 15-30 years old, Boyd and colleagues [16] also found that adiposity assessed by 
body weight was significantly inversely associated with %DBV but positively associated with 
ADBV.  Height, on the other hand, was significantly positively associated with both %DBV and 
ADBV.  
 
Height is positively associated with breast cancer risk particularly after menopause.[21, 22] The 
association of adiposity with breast cancer is complex and differs over the life course. Whereas 
obesity is positively associated with breast cancer risk after menopause, it is inversely 
associated with risk before menopause.[21, 22] Furthermore, obesity at a young age confers 
long-term protection against breast cancer that extends past menopause.[23] However, few 
studies have explored associations of height and adiposity with %DBV and ADBV in young 
women.  We, therefore, used data from the Dietary Intervention Study in Children Follow-Up 
Study (DISC06) to evaluate associations of height, adiposity and body fat distribution with 
%DBV and ADBV in a sample of women 25-29 years old. 
 
Materials and methods 
Design 
DISC was a multicenter randomized controlled clinical trial sponsored by the National Heart, 
Lung, and Blood Institute (NHLBI) to test the safety and efficacy of a dietary intervention to 
reduce serum low-density lipoprotein cholesterol (LDL-C) in children with elevated LDL-C. The 
trial’s design and results have been described previously.[24-29] Briefly, between 1988 and 
1990, 663 healthy, pre-pubertal, 8-10 year old children, including 301 girls, with elevated LDL-C 
were recruited into DISC at six clinical centers and randomized to a behavioral dietary 
intervention or usual care control group. Planned intervention continued until 1997 when the 
mean age of participants was 16.7 years. In 2006-2008 when participants were 25 to 29 years 
old, the DISC06 Follow-Up Study was conducted to evaluate the longer-term effects of the diet 
intervention on biomarkers associated with breast cancer risk in DISC female participants. 
Assent was obtained from DISC participants and informed consent was obtained from their 
parents/guardians prior to randomization. Informed consent was obtained from participants 
again prior to the DISC06 follow-up visit. The original and follow-up DISC protocols were 
approved by Institutional Review Boards at all participating centers. 
 
Participants 
All female DISC participants were invited to participate in the DISC06 Follow-Up Study and 260 
(86.4%) of the 301 females originally randomized took part. Women who were pregnant or 
breastfeeding at or within 12 weeks before the visit (n=30) and those who had breast implants 
or breast reduction surgery (n=16) were not eligible for inclusion in the current analysis leaving 
a total of 214 women. Analyses were restricted to women with complete MRI, DXA and 
anthropometric data to allow direct comparisons of associations of different measures of 
adiposity with breast density. Consequently, otherwise eligible women were excluded if they had 
technically unacceptable/missing MRI images (n=26), technically unacceptable/missing DXA 
images (n=6), technically unacceptable/missing MRI and DXA images (n=6), or missing waist 
circumference (n=1).  Finally, one participant who was highly influential in several models and 
had extreme values for %DBV and ADBV (1st percentile) and for BMI (98th percentile) and waist 
circumference (99th percentile) was excluded leaving a total of 174 participants for inclusion in 
analyses. 
 
Data collection 
For the follow-up study, each female participant attended a single visit at one of the 6 DISC 
clinics between 2006 and 2008. Visits were scheduled to take place in the luteal phase of the 
menstrual cycle whenever possible, and 85% of visits took place within 14 days of onset of next 
menses. All data for a participant were collected on the same day except 24-hour dietary 
recalls, which were collected over 2 weeks following the visit. Additionally, if a participant had 
not fasted, blood collection was re-scheduled for the following day whenever possible. Data 
were collected by staff masked to treatment assignment. A centralized data collection training 
session was held before initiation of data collection to train and certify individuals responsible for 
data collection.  
 
Participants completed several questionnaires on demographic characteristics; medical, 
reproductive and menstrual histories; medication use; and health habits including smoking.  
 
Anthropometry 
Height was measured using a stadiometer, weight was measured on an electronic or beam 
balance scale, and waist circumference was measured at the level of the uppermost lateral 
border of the right iliac crest using an anthropometric measuring tape. Each measurement was 
made twice on each participant. A third measurement was taken if the first two measurements 
were not within allowable tolerances (0.5 cm for height and waist circumference and 0.2 kg for 
weight) and the two closest values were averaged.   
 
Body composition  
Body composition was measured using clinical DXA protocols. Scans were acquired of the 
lumbar spine (L1-L4), proximal femur, and whole body at default scan speeds on Hologic 
(Hologic, Inc. Bedford, MA) and GE Lunar (General Electric/Lunar, Madison, WI) systems. All 
DXA image data was processed centrally at the University of California at San Francisco 
(UCSF) by trained staff coordinated by one of the investigators (J. Shepherd). Centralized 
analyses were performed using the manufacturers’ software (Hologic 12.4; Lunar Prodigy 11.4) 
on each scan following the guidelines of the International Society for Clinical Densitometry 
(ISCD).[30] Whole body scans include reported values for subregional values including the 
arms, legs, trunk, head, android and gynoid regions (Figure 1). Because of the substantial 
correlation between android and gynoid fat mass, relative fat distribution was characterized as 
the android:gynoid (A:G) fat mass ratio in the analyses. Total adiposity was characterized by 
percent whole body fat mass estimated by the ratio of whole body fat mass to whole body total 
mass. 
 
Different DXA systems were used at the 6 DISC clinical centers. Systems of the same make 
and model were cross calibrated to one reference site using a set of static calibration objects 
(i.e. phantoms). Inter-manufacturer calibration for spine and hip was accomplished using the in 
vivo universal standardization equations,[31, 32] whereas whole-body results were cross 
calibrated using equations derived by UCSF from unpublished data. Furthermore, device-
specific spine and whole body phantoms were scanned routinely throughout the course of the 
study to allow correction for any calibration drifts. To insure accuracy and uniformity of data 
acquisition at the different clinical sites, all DXA personnel were trained by UCSF personnel on 
the protocol, patient positioning, data transfer, and phantom scanning procedures. The clinical 
center was not certified to recruit study participants until test data on 5 volunteers met UCSF’s 
quality assurance standards. Over the course of this study, 10 scans out of the total 666 scans 
acquired were excluded by UCSF because of artifacts, motion, or poor positioning. 
 
Breast density  
Breast density was measured using non-contrast MRI. Equipment standards were consistent 
with American College of Radiology (ACR) guidelines for breast MRI[33] and required that 
imaging be performed using a whole-body 1.5 Tesla or higher field strength MRI scanner and 
dedicated breast imaging radiofrequency coil. A standard image acquisition protocol was 
prescribed consisting of two 2 pulse sequences performed in both the transaxial and coronal 
orientations with a 32-40 cm field-of-view for bilateral coverage:  1) 3D fast gradient echo 
sequence without fat-suppression; and 2) 3D fast gradient echo sequence with fat-suppression. 
 To insure accuracy and uniformity of data acquisition at the different clinical centers, MRI 
technologists at the sites were individually trained (by C. Klifa) to recognize and correct failures 
due to incomplete fat-suppression, motion artifacts, and inadequate breast coverage. In 
addition, acceptable image quality on 3 volunteers was required for site certification. Participant 
scans that were inaccurate due to artifacts, motion or technique were excluded (n=21). 
 
All MRI image data were processed at UCSF by the same investigator (C. Klifa) using 
customized software to identify the chest wall-breast tissue boundary and skin surface, and to 
separate breast fibroglandular and fatty tissue using a segmentation method based on fuzzy C-
means (FCM) clustering.[34] FCM segmentation was performed using fat-suppressed images; 
non-fat suppressed images were used when incorrect or failed segmentation occurred due to 
poor fat-suppression.  In problematic cases that could not be segmented with automated FCM 
methods, manual delineation was used. Total volumes of fibroglandular and fatty tissue were 
computed separately for each breast. %DBV was measured as the ratio of fibroglandular 
volume to total volume of the breast. ADBV also was used.   
 
Statistical analysis 
%DBV and ADBV were transformed to natural logarithms to improve normality. Adiposity 
measures were transformed to z-scores relative to the observed distribution so that a unit 
change in each measure represents a change in one standard deviation (SD) unit.  To evaluate 
associations with adiposity linear mixed effects models were fit by maximum likelihood with 
robust standard errors separately for %DBV and ADBV. Clinic was included in all models as a 
random effect; all other variables were included as fixed effects. Models were fit using backward 
stepwise elimination to ensure that we had adequate power to detect associations of interest. 
To facilitate direct comparison of associations of anthropometric and DXA-derived measures of 
adiposity with %DBV and ADBV, the same covariates were included in all adjusted models. 
Variables that were significantly associated (P < 0.05) with either %DBV or ADBV in analysis of 
anthropometric or DXA measures of body composition were included in all adjusted models. 
These models included terms for race (white, nonwhite), education (attended college), smoking 
status (current, former/never), duration of hormonal contraceptive use and parity. Regressions 
of %DBV and ADBV on height also were adjusted for current weight. To allow comparison with 
the extant literature, which generally does not adjust for childhood BMI when evaluating 
associations of adult adiposity with breast density, results are presented with and without 
adjustment for childhood BMI. BMI at 8-10 years of age expressed as a z-score relative to CDC 
2000 Growth Charts[35] to account for changes in BMI with age in childhood and adolescence 
was added to adjusted models. Treatment group, age at visit, family history of breast cancer, 
age at menarche, menstrual cycle day modeled as a cubic spline, past year leisure physical 
activity, and alcohol ingestion also were considered potential confounders but were not retained 
in final multivariable adjusted models.  Presence of interaction was evaluated by testing the 
significance of the cross-product term of variables in a model that also included their main 
effects. Mulitcollinearity was evaluated by calculating variance inflation factors (VIF) from simple 
linear regression models.[36] Potentially highly influential observations were initially identified 
using leverage-versus-squared residual plots.[37] Models were compared including and 
excluding these observations, and one observation that changed results sufficiently to change 
interpretation of the data was excluded from final analysis. Percentage differences in %DBV and 
ADBV associated with a SD difference in anthropometric and DXA body composition measures 
were estimated from models as Δ% = (exp(β) – 1) x 100. All tests of statistical significance were 
two-sided. All analyses were conducted using STATA 12.0 (College Station, TX) and SAS 9.2 
(Cary, NC).  
 
Results 
Participant characteristics are shown in Table 1. Their mean ±SD age was 27.2 ±1.0 years 
(range = 24.9 – 29.7 years) and the majority were white. The women were well educated with 
67.2% having a bachelors or graduate degree. Most (73.0%) were nulliparous.  At the time of 
the visit, 58.6% of the women were using hormonal contraceptives and 35.1% had used them 
formerly. Among current and former hormone users, the mean duration of use was 5.6 ±3.5 
years. Almost one-quarter of participants smoked cigarettes at the time of the visit with an 
average of 8.5 ±7.6 cigarettes per day. Participants’ mean BMI was 25.0 kg/m2; 25.9% were 
overweight (25 ≤ BMI < 30) and another 16.1% were obese (BMI ≥ 30).  The participants’ mean 
total fat mass measured by DXA was 25.2 kg, which was 35.4% of total mass (lean plus fat).  
Their mean android:gynoid fat mass ratio (A:G) was 0.38.   
 
Thirty-nine women who were not recently pregnant or breast feeding and did not have breast 
reduction or augmentation surgery, and consequently were eligible to be included in analyses, 
were excluded because they were missing or had technically unacceptable breast density, 
anthropometric or DXA body composition measures.  These women had a larger mean waist 
circumference compared to women included in analysis (92.0 ± 15.7 cm vs. 82.7± 12.4 cm; 
P=0.001), but otherwise they did not differ significantly on characteristics included in Table 1. 
 
Anthropometric and DXA measures of body composition and body fat distribution were 
correlated (Table 2). BMI and percent fat mass were highly correlated (Spearman r = 0.84; 
P<0.001). BMI and percent fat mass also were correlated with body fat distribution measured by 
waist circumference (Spearman r = 0.71-0.73; P<0.001) and A:G ratio (Spearman r = 0.69-0.72; 
P<0.001).  All measures of adult adiposity and body fat distribution also were positively 
correlated with BMI z-score at 8-10 years of age (Spearman r = 0.34-0.56; P<0.001), although 
less strongly than with concurrently measured BMI. 
 
Height was significantly positively associated with %DBV in adjusted analysis (Table 3). For 
each SD increase in height, %DBV increased by 18.7% (P=0.002) in the fully adjusted model. 
Height, however, was not significantly associated with ADBV in unadjusted or adjusted analysis 
(Table 4). 
 All anthropometric and DXA measures of adiposity and body fat distribution were significantly 
inversely associated with %DBV in unadjusted and adjusted analysis (Table 3). In adjusted 
models that did not include childhood BMI, each SD increase in adult BMI, percent fat mass, 
waist circumference and A:G ratio was associated significantly with approximately a 50.1 - 
52.0% decrease in %DBV (all P<0.001). BMI z-score at 8-10 years of age was independently 
and significantly inversely associated with %DBV, and after adjusting for childhood BMI in 
addition to other covariates, a unit increase in each measure of adult adiposity and body fat 
distribution was significantly associated with a 44.4 - 47.0% decrease in %DBV (all P<0.001). 
 
All anthropometric and DXA measures of adiposity also were significantly inversely associated 
with ADBV in unadjusted and adjusted analyses that did not include childhood BMI (Table 4). In 
these adjusted analyses, each SD increase in adult BMI, percent fat mass, waist circumference 
and A:G ratio was associated significantly with a 20.8 - 26.6% decrease in ADBV (all P ≤ 0.011).  
However, childhood BMI was independently and significantly inversely associated with ADBV, 
and adjustment for BMI z-score at 8-10 years of age attenuated associations of adult adiposity 
and body fat distribution with ADBV. After adjustment for childhood BMI and other covariates, 
only the DXA measures percent fat mass and A:G ratio remained significant; a SD increase in 
each was associated significantly with a 13.8% and 19.6% decrease in ADBV, respectively (all 
P<0.05). 
 
 As noted above, measures of adiposity and body fat distribution were correlated. However, 
even though mutual adjustment attenuated associations, percent fat mass and A:G ratio each 
remained significantly (P<0.001) inversely associated with %DBV (Table 5). Similarly, BMI and 
waist circumference were independently inversely associated with %DBV. In contrast, although 
A:G ratio remained significantly inversely associated with ADBV after adjustment for percent fat 
mass, percent fat mass was no longer significantly associated after adjustment for A:G ratio.  
Adjusted for percent fat mass, a SD increase in A:G ratio was associated significantly with a 
18.5% decrease in ADBV (P<0.001). Even though measures of total adiposity and body fat 
distribution were highly correlated, the highest VIF for individual variables included in models 
was 2.98 and the highest model average VIF was 1.60 indicating that multicollinearity was not a 
serious problem.[36]  
 
Women in our study participated in a controlled clinical trial of a diet intervention during 
childhood and adolescence. Approximately half were randomly assigned to the intervention 
group and half to the usual care control group. Tests for interaction did not indicate that group 
assignment modified associations of height or anthropometric and DXA measures of adiposity 
with %DBV or ADBV (data not shown). 
 
Discussion 
 
Adiposity and body fat distribution were strongly inversely associated with %DBV in this study of 
25-29 year old women.  Associations were weaker for ADBV but remained significant in 
adjusted analysis for the DXA measures percent fat mass and A:G ratio. Percent fat mass and 
A:G ratio were independently inversely associated with %DBV, but in mutually adjusted analysis 
only A:G ratio remained significantly inversely associated with ADBV. Height was positively 
associated with %DBV but was not associated with ADBV. Research is needed to identify the 
physiological mechanisms underlying these associations.  
Our study had several strengths.  Data collection was performed using standardized procedures 
by trained personnel and numerous quality controls were in place to ensure data integrity. 
%DBV and ADBV were measured by MRI, which is a tomographic rather than projection 
technique, and therefore, not impaired by high parenchymal breast density, making it especially 
effective for younger women with dense breast tissue.  MRI can easily distinguish dense 
fibroglandular breast tissue from fatty breast tissue with a high degree of contrast and gives 
three-dimensional information not provided by mammography. Even though %DBA and %DBV 
are highly correlated,[16, 34, 38] volumetric measures of percent breast density have been 
reported to be more strongly associated with breast cancer risk compared to area measures.[2] 
Body composition was measured by DXA, which yields accurate and precise estimates of 
adiposity,[39, 40] and estimation of the A:G ratio enabled discrimination of associations of total 
adiposity and body fat distribution with %DBV and ADBV.  Data were available from the original 
DISC trial on childhood BMI z-score, which was an independent predictor of breast density in 
our analysis. 
 
Our study also had some limitations. All participants had elevated LDL-C as children when they 
were randomized in DISC and met several additional eligibility criteria, which could reduce 
generalizability of findings. In an analysis by Boyd and colleagues,[41] LDL-C was significantly 
inversely associated with %DBA after adjusting for age and BMI, but in an analysis by 
Tamburrini and colleagues,[42] the association was no longer significant after adjusting for waist 
circumference. We observed a non-significant inverse correlation of LDL-C with %DBV in the 
current analysis (r = -0.12, P = 0.11) after adjustment for age and BMI. LDL-C also was not 
correlated with ADBV in analysis adjusted for age and BMI.  Moreover, only 14 (8.0%) 
participants included in analyses had high LDL-C levels at follow-up visits based on National 
Cholesterol Education Program guidelines,[43] and none were using cholesterol lowering 
medications. We measured body composition by DXA, which does not distinguish metabolically 
distinct visceral abdominal fat from subcutaneous fat.  DXA measures of android fat, however, 
are highly correlated with estimates of visceral fat obtained by MRI.[39] Because total fat mass, 
android fat mass and gynoid fat mass were highly correlated, it was not possible to evaluate 
their independent associations with %DBV and ADBV. The A:G ratio measures body fat 
distribution and was used instead. 
 
Thirty-nine otherwise eligible women were excluded from the current analysis because they had 
missing or technically unacceptable MRI or whole-body DXA images or waist circumference.  
These women had a larger mean waist circumference compared to women included in analysis 
but did not differ on other characteristics evaluated. Technically unacceptable MRIs were a 
consecutive series from a single clinic where participants’ mean waist circumference was higher 
compared to the other clinics. Women with technically unacceptable whole-body DXA scans 
also had larger waist circumferences compared to other women, which could have been due to 
difficulties fitting into the DXA scanning region. Missing MRI and DXA scans were not related to 
waist circumference. 
 
BMI is an indirect measure of body fat, and although highly correlated with direct measures of 
percent fat mass and used extensively as a measure of adiposity, it has known limitations. The 
relationship of BMI to percent fat mass is non-linear and differs between men and women.[44] 
Furthermore, BMI tends to overestimate body fat in lean individuals with high muscle mass.  
Even so, in our analysis associations of BMI and percent fat mass with %DBV were 
comparable.  Associations of ADBV with BMI were slightly weaker than percent fat mass, but 
interpretations generally were similar except when adjusted for childhood BMI z-score. 
Childhood BMI z-score was more strongly correlated with adult BMI than with adult percent fat 
mass, and adjustment for childhood BMI z-score attenuated the association of ADBV with adult 
BMI to a greater extent than percent fat mass such that only the association of percent fat mass 
with ADBV remained statistically significant.  
 
Total adiposity, estimated by BMI or percent fat mass, was significantly inversely associated 
with %DBV in our study. These results are consistent with earlier studies in premenopausal,[3-
5, 7, 9-11, 14, 16] postmenopausal [4-8, 10, 13, 14] and combined pre- and postmenopausal 
[12, 15] women that report inverse associations with adiposity regardless of whether percent 
density was measured by area [3-13] or volume[12-16]. In contrast, the association of adiposity 
with absolute density varies across studies, possibly due to differences in populations studied 
and measurement of ADBA versus ADBV. Although ADBA and ADBV are positively correlated 
(r ~ 0.33), these correlations are considerably weaker compared to %DBA and %DBV (r = 
0.76).[38] The majority of studies in postmenopausal women report inverse associations of 
ADBA with BMI and percent fat mass that are weaker compared to %DBA.[6-8, 10, 13] The 
association of ADBA with adiposity in premenopausal women is less consistent with significant 
inverse [3, 7, 10] and direct [8, 9, 11] associations reported. In contrast, the association of 
adiposity with ADBV is more often reported to be direct,[12, 14-16] although inverse [13] and 
null [17] associations also have been reported. None of these studies adjusted for childhood 
BMI, which as described above, attenuated inverse associations of adult BMI and percent fat 
mass with ADBV in our study. 
 
Mutual adjustment for percent fat mass and A:G ratio unveiled important differences in 
associations of total adiposity and body fat distribution with %DBV and ADBV. Specifically, 
whereas percent fat mass and body fat distribution were independently and inversely associated 
with %DBV, only body fat distribution was associated with ADBV in mutually adjusted analysis. 
Women with more central or android fat mass relative to gynoid fat mass had significantly less 
ADBV. Our findings for A:G ratio are consistent with earlier reports of inverse associations of 
abdominal fat measured by waist circumference, waist-to-hip ratio, DXA percent trunk fat or 
computed tomography (CT) abdominal fat area with %DBV and %DBA [4, 8, 10, 11, 13] and 
with ADBV and ADBA [4, 8, 10, 13] in pre- and postmenopausal women. Similar to our findings, 
Tseng and Byrne [11]reported independent inverse associations of total and abdominal 
adiposity with %DBA, whereas in the study by Woolcott and colleagues, [13] only abdominal 
adiposity remained significantly associated with %DBA in models that included measures of 
total and abdominal adiposity.  In the latter study, mutual adjustment attenuated associations of 
both total adiposity and abdominal adiposity such that neither remained significantly associated 
with ADBA.   
 
Inverse associations of A:G ratio with %DBV and ADBV that we observed could reflect inverse 
associations of android fat mass or direct associations of gynoid fat mass with these measures 
of breast density.  Accumulation of abdominal visceral fat is associated with an adverse 
metabolic profile that includes insulin resistance [40, 45] and suppression of the growth 
hormone axis.[45, 46] Most studies do not support an association of insulin resistance with 
%DBA or ADBA that is independent of adiposity, [47, 48] but growth hormone is the primary 
secretagogue for insulin-like growth factor -1 (IGF-1), which is positively associated with %DBA 
and ADBA in premenopausal women.[49-51] Thus, lower levels of IGF-1 in association with 
abdominal obesity could potentially underlie inverse associations of the A:G ratio with %DBV 
and ADBV.  Alternatively, visceral fat varies inversely with estrogens [52] and lower estrogens in 
association with a high A:G ratio also could potentially explain its inverse association with 
%DBV and ADBV.  
 
Height was significantly positively associated with %DBV in adjusted analysis, but it was not 
associated with ADBV in adjusted or unadjusted analysis. Boyd previously reported significant 
positive associations of height with %DBA,[3] %DBV,[16] and ADBV [16] in premenopausal 
women and suggested that growth hormone, which also was positively associated with 
%DBV,[16] might mediate this association. Height is positively associated with %DBA in some 
[3, 7, 18] but not all [6, 10, 11] studies.  In contrast, height generally is not associated with 
ADBA, [3, 6, 10, 11, 18] although a significant but weak positive correlation was reported in a 
study of young women.[16]  Height also was positively associated with ADBV in that study, 
which is in contrast to the null association that we observed.  
 
Body composition was evaluated in association with breast density in young women in two prior 
studies.  Similar to us, in a study of 25-35 year olds, Furberg and colleagues[19] reported an 
inverse association of BMI and percent truncal fat with percent breast density assessed by 
mammographic parenchymal patterns. Findings from our study and the study in young women 
by Boyd and colleagues[16] on associations of height and adiposity with %DBV also were 
similar, but differed for ADBV. The reason for these differences is unclear. However, our studies 
differed in important ways. Age is an important determinant of %DBV and ADBV,[16] and 
participants in our study were 25-29 years old compared to 15-30 years old in the study by Boyd 
and colleagues.[16] Some of the younger girls in the latter study may not have attained final 
adult height or completed breast development at the time of assessments. Girls had to be at or 
above the 5th percentile for height and within the 5th to 95th percentile of weight for height when 
8-10 years old to be eligible for DISC and consequently our study. The mean height of Boyd and 
colleagues’[16] participants was similar to ours at follow-up visits (165.8 ± 5.9 cm vs. 165.1± 6.3 
cm), but our participants tended to weigh more (60.6 ± 10.5 kg vs. 68.0 ± 13.4 kg). Boyd and 
colleagues[16] used body weight as a measure of adiposity, whereas we used BMI and percent 
fat mass measured by DXA. However, our results were unchanged by substituting weight for 
BMI and adjusting for height as Boyd and colleagues did (data not shown). Breast MRIs were 
performed mostly in the luteal phase of the menstrual cycle in our study but in the follicular 
phase in Boyd and colleagues’ study.[16] Although variation in %DBV and ABDV across the 
menstrual cycle generally is less than 10%, [53, 54] larger fluctuations have been reported [53, 
55] and could have contributed to differences in findings. Boyd and colleagues’[16] estimates of 
%DBV and ADBV were substantially larger than ours, and technical differences in estimating 
%DBV and ADBV also could have contributed to differences in observed associations. Finally, 
models in the two studies differed in terms of covariates included. 
 
The association of adiposity with breast cancer is complex. Whereas obesity is inversely 
associated with breast cancer in premenopausal women, it is positively associated with risk in 
postmenopausal women.[21, 22] The inverse association that we observed between adiposity 
and %DBV and ADBV is consistent with obesity’s protective effect for breast cancer in young 
women.  Childhood obesity confers long-term protection against breast cancer risk [23] and has 
been reported to be inversely associated with breast density measured by mammographic 
parenchymal patterns[56] and %DBA.[57] In our analysis BMI z-score at 8-10 years of age was 
inversely associated with %DBV and ADBV, and adjustment for childhood BMI attenuated 
associations of adult BMI with ADBV by 67 percent, but %DBV by only 10 percent. The non-
dense compartment of the breast is composed of adipose tissue, and not surprisingly %DBV, 
which is the ratio of dense-to-dense plus non-dense breast volume, was more strongly 
associated with current adiposity than childhood adiposity.  However, childhood BMI was a 
strong independent predictor of ADBV and explained much of the association of adult BMI with 
ADBV. The mechanisms underlying these associations currently are unknown.  However, 
childhood adiposity and associated metabolic, hormonal and inflammatory factors potentially 
could program breast development at a critical time leading to life-long changes in breast 
morphology, breast density and breast cancer risk. Differences in unmeasured childhood 
adiposity also could contribute to inconsistencies in the literature on associations of adult 
adiposity with ADBA and ADBV noted above.  
 
Conclusions 
In conclusion, in young women adiposity and body fat distribution are significantly and 
independently inversely associated with %DBV. Associations with ADBV are weaker and more 
complex. Total adiposity measured as percent fat mass and body fat distribution are significantly 
inversely associated with ADBV, but with mutual adjustment only body fat distribution remained 
significant.  Height is significantly positively associated with %DBV. Additional research is 
needed to identify the biological mechanisms underlying these associations.  
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Figure legends  
Figure 1 
DXA scan with the android region outlined in blue and the gynoid region outlined in pink. 
 
Table 1. Participant Characteristics 
Descriptive Characteristics N Mean (SD) 
Age, y 174 27.16 (1.02) 
Duration hormone use by current and former users, y 163  5.64 (3.52) 
Number of cigarettes per day by current smokers   40  8.53 (7.55) 
BMI z-score at 8-10 years old 174    0.20 (0.89) 
   
 N % 
Race   
    White 156 89.66 
    Non-white   18 10.34 
Education   
    High school, vocational or technical school   18 10.34 
    Some college   39 22.41 
    Bachelor degree   92 52.87 
    Graduate degree   25 14.37 
Number of Full Term Pregnancies   
    0   127 72.99 
    1    28 16.09 
    2 - 4    19 10.92 
Hormone use   
    Never   11 6.32 
    Former   61 35.06 
    Current 102 58.62 
Smoking Status   
    Never   97 55.75 
    Former   37 21.26 
    Current   40 22.99 
   
Anthropometric Measures N Mean (SD) 
Height, cm 174 165.09 (6.35) 
Waist, cm 174     82.67 (12.36) 
BMI, kg/m
2
 174  24.97 (4.82) 
   
DXA Body Composition Measures N Mean (SD) 
Total fat, % 174 35.40(8.80) 
Android:Gynoid fat  mass ratio (A:G) 174 0.38 (0.12) 
   
Breast Density Measures N Mean (SD)) 
Percent dense breast volume, % 174 28.15 (20.39) 
Absolute dense breast volume, cm
3
 174 104.67 (71.28) 
a
IQR = interquartile range 
 
  
 
Table 2: Spearman Correlations of Anthropometric and DXA Body Composition Measures 
 Height, 
cm 
BMI, 
kg/m
2
 
Waist, 
cm 
Total 
Fat, % 
A:G 
Ratio
a
, g 
BMI at 8-10 
years old, z-
score 
Height, cm     1.00      
BMI, kg/m
2
 -0.19 1.00     
Waist, cm <0.01 0.71 1.00    
Total Fat, % -0.15 0.84 0.73 1.00   
A:G Ratio, kg -0.16 0.69 0.66 0.72 1.00  
BMI at 8-10 years old, 
z-score 
0.05 0.56 0.37 0.42 0.34 1.00 
 
a
 Android:Gynoid Fat Ratio. 
b
 Bolded correlations are statistically significant at p<.001
  
 
 
Table 3.  Percentage Difference in Percent Dense Breast Volume Associated with a One Standard Deviation Difference in 
Anthropometric and DXA Body Composition Measures  
 Unadjusted  Adjusted   
Also adjusted for childhood or young 
adult BMI  
 % Diff 95% CI p R  % Diff 95% CI p R  % Diff 95% CI p R  
Adult Anthropometric Measures 
Height, cm       3.7 -13.8, 24.8    0.70 <0.01 21.0 9.4, 33.8  <0.001 0.55 18.7 6.7, 32.1   0.002 0.57 
BMI, kg/m
2
 -50.2 -55.0, -44.8 <0.001 0.49 -50.2 -55.4, -44.4 <0.001 0.54 -45.1 -51.5, -37.8 <0.001 0.56 
Waist, cm -51.9 -58.8, -43.8 <0.001 0.38 -51.5 -59.7, -41.6 <0.001 0.47 -44.4 -51.0, -37.0 <0.001 0.56 
Adult DXA Measures 
Total Fat, % -50.8 -55.0, -46.4 <0.001 0.53 -50.1 -55.0, -44.7 <0.001 0.55 -44.4 -49.6, -38.7 <0.001 0.60 
A:G Ratio
f
, kg -52.3 -55.6, -48.8 <0.001 0.57 -52.0 -54.5, -49.5 <0.001 0.60 -47.0 -48.5, -45.4 <0.001 0.67 
Childhood BMI 
BMI z-score at 
age 8-10 yrs 
-40.0 -47.0, -32.0 <0.001 0.22 -41.7 -47.5,  -35.2 <0.001 0.34 -17.3 -22.4, -11.9 <0.001 0.56 
a
 Results also are interpretable as the excess relative ratio. To convert to the relative ratio (RRatio) use the formula 
RRatio = (%Diff + 100)/100. 
b 
Estimates from 6 linear mixed effects models including clinic as a random effect and 
anthropometric and body composition variables as fixed effects. Anthropometric and body composition variables are 
modeled separately without mutual adjustment. 
c
 Estimates from 6 linear mixed effects models as described above 
under ‘a’ plus including race, education (attended college), smoking status, duration of hormone use, and parity as 
fixed effects. Model for height also includes weight as a fixed effect. 
d 
Estimates from 6 linear mixed effects models as 
described above under ‘b’ plus including BMI z-score at 8-10 years old as a fixed effect  in adult anthropometric and 
DXA models and young adult BMI in childhood BMI model. 
e
 Proportion of variance explained by model. 
f 
Android:Gynoid fat ratio.
  
 
Table 4. Percentage Difference in Absolute Dense Breast Volume Associated with a One Standard Deviation Difference in 
Anthropometric and DXA Body Composition Measures  
 Unadjusted  Adjusted   
Also adjusted for childhood or young 
adult BMI  
 % Diff 95% CI p R  % Diff 95% CI p R  % Diff 95% CI p R  
Adult Anthropometric Measures 
Height, cm      -8.9 -22.2, 6.8 0.25 0.01 -2.5 -12.6, 8.7 0.65 0.19 -5.6 -15.5, 5.4 0.31 0.26 
BMI, kg/m
2
 -20.4 -29.6, -10.0 <0.001 0.07 -20.8 -29.8, -10.7 <0.001 0.17 -6.8 -18.9, 7.0 0.32 0.25 
Waist, cm -23.7 -37.7, -6. 7 0.009 0.08 -24.7 -39.5, -6.3 0.011 0.20 -15.6 -32.1, 4.8 0.12 0.28 
Adult DXA Measures 
Total Fat, % -24.6 -33.9, -14.1 <0.001 0.12 -23.7 -32.9, -13.1 <0.001 0.20 -13.8 -24.1, -2.3 0.02 0.28 
A:G Ratio
f
, kg -26.9 -35.4, -17.3 <0.001 0.14 -26.6 -34.2, -18.2 <0.001 0.23 -19.6 -27.1, -11.2 <0.001 0.30 
Childhood BMI 
BMI z-score at 
age 8-10 yrs 
-28.4 -37.3, -18.3 <0.001 0.13 -30.0 -35.9, -23.5 <0.001 0.25 -27.0 -32.9, -20.7 <0.001 0.25 
 
a
 Results also are interpretable as the excess relative ratio. To convert to the relative ratio (RRatio) use the formula 
RRatio = (%Diff + 100)/100. 
b 
Estimates from 6 linear mixed effects models including clinic as a random effect and 
anthropometric and body composition variables as fixed effects. Anthropometric and body composition variables are 
modeled separately without mutual adjustment. 
c
 Estimates from 6 linear mixed effects models as described above 
under ‘a’ plus including race, education (attended college), smoking status, duration of hormone use, and parity as 
fixed effects. Model for height also includes weight as a fixed effect. 
d 
Estimates from 6 linear mixed effects models as 
described above under ‘b’ plus including BMI z-score at 8-10 years old as a fixed effect  in adult anthropometric and 
DXA models and young adult BMI in childhood BMI model. 
e
 Proportion of variance explained by model. 
f 
Android:Gynoid fat ratio.
 
Table 5. Percentage Difference in Percent and Absolute Dense Breast Volume with a One Standard Deviation 
Difference in Mutually Adjusted Anthropometric and DXA Measures
a
 
 Percent Dense Breast Volume  Absolute Dense Breast Volume  
 % Diff 95% CI p R  % Diff 95% CI p R  
       
BMI, kg/m
2
 -29.1 -48.2, -3.1     0.03 0.61 13.4 -19.1, 58.8 0.47 0.29 
Waist Circumference, cm -28.6 -49.4, -0.7     0.06  -22.5 -47.9, 15.2 0.21  
         
        
Total Fat, % -26.1 -34.1, -17.3   <0.001 0.71 -2.4 -16.7, 14.3 0.76 0.30 
A:G Ratio
d
, kg -37.2 -40.3, -34.0   <0.001  -18.5 -27.8, -7.9  0.001  
 
a 
 Results also are interpretable as the excess relative ratio. To convert to the relative ratio (RRatio) use the formula  
RRatio = (%Diff + 100)/100. 
b  
Estimates from 2 linear  mixed effects models including clinic as a random effect and 
anthropometric and body composition variables, race, education (attended college), smoking status, duration of 
hormone use, parity, and BMI z-score at 8-10 years of age as fixed effects. 
c
 Proportion of variance explained by 
model. 
d 
Android:Gynoid fat ratio. 

